L’avis urgent intitulé « Utilisation du vaccin IXCHIQ dans le contexte épidémique de chikungunya dans les territoires de La Réunion et de Mayotte », ci-joint, est adopté.
See also
Vaccine recommendation
05/03/2025
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
wpC7djMSmbWLrqZ5
